Barely Significant
← all excerpts

The Growth Modulation Index (GMI) as an Efficacy Outcome in Cancer Clinical Trials: A Scoping Review with Suggested Reporting Guidelines.

Curr Oncol Rep · 2025 · PMC12081581 · PMID 40156702

1
hedged sentence
closest p
boldest claim

The sentences

an increasing trendno p-value reported
We highlighted an increasing trend over years in the use of the GMI, whether it relates to the reporting of clinical studies or to methodological publications.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.